减影CTA:血流导向装置治疗动脉瘤随访的替代影像选择?
本试点研究纳入2015年11月至2016年11月间接受血流导向装置治疗未破裂颅内动脉瘤的患者,评估减影CTA联合单能金属伪影减少算法(SEMAR)与DSA相比诊断动脉瘤闭塞的准确性和安全性。共评估13个颅内动脉瘤,减影CTA检测动脉瘤闭塞的敏感度和特异度均为100%(95% CI分别为82.41%-100%和67.55%-100%),读者间一致性完美(κ=1.0),减影CTA上检测到的最小瘤颈残余为1.2 mm,无并发症发生。作者认为减影CTA联合SEMAR可有效减少血流导向装置的金属伪影,可能成为血流导向装置治疗后评估颅内动脉瘤闭塞的可行替代方法。
要点
- 减影CTA联合SEMAR检测血流导向装置治疗后动脉瘤闭塞的敏感度和特异度均为100%。
- 减影CTA可检测到最小1.2 mm的瘤颈残余,读者间一致性完美(κ=1.0)。
- 减影CTA可能成为血流导向装置治疗后评估动脉瘤闭塞的可行替代方法。
核心结论
- 减影CTA联合单能金属伪影减少算法可有效减少血流导向装置的金属伪影,可能成为血流导向装置治疗后评估颅内动脉瘤闭塞的可行替代方法。
研究设计与样本
- 试点研究,纳入2015年11月至2016年11月间接受血流导向装置治疗的未破裂颅内动脉瘤患者,分为血流导向装置治疗后1个月随访组和已知残余动脉瘤定期随访组;采用320排CT系统行全脑减影CTA,DSA在平板C臂血管造影系统上进行;以Raymond量表评估动脉瘤闭塞为主要结局指标,由2名临床医生独立评分。
诊断标准与关键数值
- 减影CTA检测动脉瘤闭塞的敏感度为100%(95% CI,82.41%-100%),特异度为100%(95% CI,67.55%-100%);读者间一致性完美(κ=1.0);减影CTA上检测到的最小瘤颈残余为1.2 mm。
临床应用与阅片要点
- 作者认为减影CTA联合单能金属伪影减少算法可有效减少血流导向装置的金属伪影,可能成为血流导向装置治疗后评估颅内动脉瘤闭塞的可行替代方法。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND AND PURPOSE: This was a pilot study to explore the diagnostic accuracy and safety of subtraction CTA combined with a single-energy metal artifact reduction algorithm (SEMAR) compared to DSA for the evaluation of intracranial aneurysm occlusion after flow diverter treatment.
MATERIALS AND METHODS: We included patients treated with a flow diverter for an unruptured intracranial aneurysm between November 2015 and November 2016. The patient cohort comprised 2 groups: those who underwent follow-up imaging 1 month after flow-diverter treatment and those with a known residual intracranial aneurysm after flow diverter treatment who underwent imaging at regular follow-ups. Full-brain subtraction CTA was performed on a 320-detector row CT system. A low-dose non-enhanced volume acquisition was followed by a contrast-enhanced volume CTA. Iterative and noise-reduction filters, SEMAR, and SURESubtraction algorithms were applied. DSA was performed on a flat panel C-arm angiography system. Standard posteroanterior, lateral, 3D, and detailed 2D acquisitions were performed. Imaging was independently scored by 2 clinicians. Aneurysm occlusion (Raymond scale) was our primary outcome parameter.
RESULTS: Thirteen intracranial aneurysms were evaluated with subtraction CTA and DSA. Nine aneurysm remnants were demonstrated by both subtraction CTA and DSA. The sensitivity and specificity of subtraction CTA for the detection of aneurysm occlusion were 100% (95% CI, 82.41%-100%) and 100% (95% CI, 67.55%-100%), respectively. Agreement between readers was perfect (κ = 1.0). The smallest neck remnant detected on subtraction CTA was 1.2 mm. No complications occurred.
CONCLUSIONS: Subtraction CTA with single-electron metal artifact reduction is effective in the reduction of metal artifacts of flow diverters and might therefore be a viable alternative in the assessment of intracranial aneurysm occlusion after flow diverter treatment.
引用
- Duarte Conde MP, de Korte AM, Meijer FJA, et al. Subtraction CTA: An Alternative Imaging Option for the Follow-Up of Flow-Diverter-Treated Aneurysms? AJNR Am J Neuroradiol. 2018. PMID: 30287460. doi:10.3174/ajnr.A5817
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。